Morality and biotechnology patent laws
by Joanne Yong
International Journal of Private Law (IJPL), Vol. 3, No. 1/2, 2010

Abstract: Patent law reform should be done through an ethical dimension. Biotechnology patent laws are in a state of crisis because they are lacking in an adequate moral underpinning. The utilitarian nature of law in general prevents it from being a strong moral advocate. It is thus necessary to look beyond law reform per se to resolve the patent law crisis. Introducing corporate social responsibility into the biotechnology and pharmaceutical industries may resolve some of the problems that biotech patent laws are facing.

Online publication date: Mon, 30-Nov-2009

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Private Law (IJPL):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com